In gastric, tongue, and bladder carcinoma, PDLIM3 is also overexpressed compared to corresponding healthy tissues and could be a predictive factor for tumor progression and survival of patients with these cancers (Feng et al. 2020, Lee et al. 2021, Hu et al. 2022). Here, PDLIM3 is linked to neoplasm.